Form 4: Merus N.V. CFO Gregory D. Perry Awarded 100,000 Share Options
SEC Form 4 Filing
Merus N.V.'s Chief Financial Officer, Gregory D. Perry, was granted 100,000 share options on January 29, 2025, which vest over a four-year period.
Summary
- Gregory D. Perry, the Chief Financial Officer of Merus N.V., was granted 100,000 share options on January 29, 2025.
- The options have an exercise price of $41.65.
- The options vest over a four-year period, starting January 1, 2025.
- 25% of the options will vest on January 1, 2026, with the remaining options vesting in 36 equal monthly installments thereafter.
- The options expire on January 29, 2035.
Sentiment
Score: 7
Explanation: The document reflects a standard executive compensation practice, which is generally viewed positively as it aligns management with shareholder interests. There are no negative implications.
Positives
- The grant of share options to the CFO aligns his interests with those of the shareholders.
- The vesting schedule encourages long-term commitment from the CFO.
Industry Context
Share option grants are a common form of executive compensation in the biotechnology industry, aligning management's interests with the long-term performance of the company.
Comparison to Industry Standards
- Share option grants are a standard practice for compensating executives in publicly traded companies, particularly in the biotech sector.
- Vesting schedules, such as the four-year period with a cliff vest followed by monthly installments, are also common to incentivize long-term performance and retention.
- The specific terms of the grant, such as the exercise price and vesting schedule, are generally aligned with industry norms for companies of similar size and stage of development.
Stakeholder Impact
- Shareholders may view the option grant positively as it incentivizes the CFO to work towards increasing the company's value.
- Employees may see this as a positive sign of the company's commitment to its leadership.
Key Dates
| Date | Description |
|---|---|
| 01/29/2025 | Date of the share option grant. |
| 01/01/2025 | Start date of the vesting period. |
| 01/01/2026 | Date when 25% of the options vest. |
| 01/29/2035 | Expiration date of the share options. |
| 01/31/2025 | Date the form was signed. |
Keywords
share options, stock options, executive compensation, vesting, Merus N.V., MRUS, Gregory D. Perry, CFO
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.